Peripheral neuropathy (length-dependent polyneuropathy)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First-line tests (cause not obvious)
Fasting laboratory tests
- Fasting plasma glucose
- FBC (with MCV)
- GGT
- AST
- ALT
- Serum creatinine with eGFR
- CRP
- TSH
- Vitamin B12
- Serum protein electrophoresis
- Serum protein immunofixation (straight away if monoclonal gammopathy strongly suspected)if neededThe AAN recommends immunofixation, more sensitive than electrophoresis alone [2]. In France, the laboratory can do it on its own initiative if the electrophoresis is abnormal [3]: prescribe it from the outset especially for an ataxic sensory-predominant or demyelinating neuropathy, in which an IgM paraprotein is possible [4].
- Oral glucose tolerance test (if fasting plasma glucose normal)if needednon-French guidelineDistal sensory polyneuropathy without diabetes proven by fasting plasma glucose: the AAN suggests looking for glucose intolerance [1,2].
- HbA1c (if fasting plasma glucose normal)if needednon-French guidelineThe Dutch neurologists' recommendation (NVN, 2019) includes glucose and HbA1c in the baseline tests for any polyneuropathy, diabetes being the leading cause of polyneuropathy in Western populations [5].
- Vitamin B6 (if vitamin supplements, vegetarian or vegan diet)if needednon-French guidelineThe Dutch recommendation (NVN, 2019) measures vitamins B1, B6, B12 and folate in the baseline tests for any chronic polyneuropathy, to detect treatable deficiencies and avoidable vitamin B6 toxicity, given the spread of vegetarian or vegan diets and vitamin supplements; it judges this measurement relatively costly but useful [5]. The HAS (2007) cites excess vitamin B6 among the toxic causes, without providing for its measurement [4].
- Vitamin B1 (if excessive alcohol consumption)if needednon-French guidelineThe Dutch recommendation (NVN, 2019) measures vitamin B1 in the baseline tests for any chronic polyneuropathy and notes that vitamin deficiencies are more frequent in patients who drink too much alcohol [5,6]. The HAS (2007) points out that alcoholic neuropathy associated with a vitamin or nutritional deficiency can improve with abstinence and adequate nutrition, without providing for a measurement [4].
- HIV serology (if at-risk situation)if neededAt-risk situation or known infection: the HAS has AIDS looked for in the history; HIV causes distal polyneuropathies and mononeuritis multiplex [4].
- Hepatitis C serology (if at-risk situation or mononeuritis multiplex)if neededHepatitis or at-risk situation in the history, or mononeuritis multiplex (hepatitis C, cryoglobulinaemia) [4].
- Plasma homocysteine, methylmalonic acid and folate (nitrous oxide use)if needednon-French guidelineRecreational use of nitrous oxide, even in the past or initially denied (siphon cartridges, canisters): serum B12 can remain normal despite functional deficiency; homocysteine indicates recent exposure, methylmalonic acid reflects severity, folate worsens hyperhomocysteinaemia [7]. Sample as early as possible: these markers normalise quickly after stopping or supplementation; interpret methylmalonic acid according to GFR [7].
Do not order
- Nerve conduction studies and EMG as first-line test: the HAS does not recommend them from the outset; they are useless when an obvious cause explains a typical picture [4]
- Anti-ganglioside antibodies: their diagnostic value is limited and technique-dependent, even in Guillain-Barré syndrome [8]; like other specialised tests, they are requested only for atypical signs [1]
- Rheumatological tests (autoantibodies) as a routine: low yield in distal symmetrical polyneuropathy [1]
- Brain or spinal MRI: rarely indicated in distal symmetrical polyneuropathy, yet often requested [1]
Sources (8)
- Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314(20):2172-81.
- England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, AANEM and AAPM&R. Neurology. 2009;72(2):185-92.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 0570 (protéinogramme), 1571 et 1572 (immunofixation), 1577 (HbA1c).
- Haute Autorité de santé. Prise en charge diagnostique des neuropathies périphériques (polyneuropathies et mononeuropathies multiples). Recommandations professionnelles, mai 2007.
- Nederlandse Vereniging voor Neurologie (NVN). Richtlijn Polyneuropathie, module « Laboratoriumonderzoek zonder alarmsymptomen bij polyneuropathie », publié le 5 juillet 2019. Richtlijnendatabase, Federatie Medisch Specialisten.
- Nederlandse Vereniging voor Neurologie (NVN). Richtlijn Polyneuropathie, module « Laboratoriumonderzoek bij bekende risicofactor van polyneuropathie », 2019. Richtlijnendatabase, Federatie Medisch Specialisten.
- Grzych G, Lee GR, Alpdemir M, Gernez E, Anseeuw K, Bjorke-Monsen AL, et al. Addressing the silent epidemic of recreational nitrous oxide use: a position, call to action and recommendations by the European Federation of Clinical Chemistry and Laboratory Medicine Committee on Biological Markers of Nitrous Oxide Abuse. Clin Chem Lab Med. 2026;64(4):813-20.
- Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671-83.